Wagner Santiago, DPM
Podiatrist · Gastonia, NCNPI 1306831854
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,177 of the $7,011 with a category attached, or 73.8%. It is spread thinly across 49 manufacturers, the largest accounting for just 19.3%. Reporting peaked in 2022 at $2,078 and has fallen 67.2% since, to $681 in 2025.
Across 178 payments — averaging $39.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Triad Life Sciences Inc.$1K
- Medline Industries LP$1K
- Amgen$681
- Convatec Inc.$565
- Nevro Corp.$403
- Stryker$338
- plus $2K from 43 others
What the payments were for
- Travel & lodging$1,83426%
- Food & beverage$5,17774%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$1,158
- KRYSTEXXA$486
- AQUACEL AG$125
- Senza$103
How this compares
$7,011 in reported general payments places this provider in the 85th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 33 | $491 |
| Terbinafine Hcl | 103 | $448 |
| Gabapentin | 61 | $432 |
| Cephalexin | 12 | $373 |
| Silver Sulfadiazine | 30 | $334 |
| Colchicine | 13 | $179 |
| Minocycline Hcl | 17 | $168 |
| Meloxicam | 30 | $128 |
| Prednisone | 15 | $113 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $100 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $93 |
| Clindamycin Hcl | 13 | $90 |
| Allopurinol | 17 | $54 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Gastonia
- Wilbur MeredithGastonia$4K
- David KirlinGastonia$3K
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Robert PrzynoschWaynesville$9K
- William BanksWaynesville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.